HIV/AIDS services in private substance abuse treatment programs

Drug and Alcohol Dependence

Volumn 115, Issue 1-2, 2011, Pages 16-22

  Abraham, Amanda J ^a   O'Brien, Lauren A ^a   Bride, Brian E ^a   Roman, Paul M ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

HIV testing; HIV AIDS services; Substance abuse treatment

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICAN AMERICAN; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE TREATMENT; HEALTH PROGRAM; HIV TEST; HOSPITAL SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MEDICAL CARE; OUTPATIENT CARE; PATIENT REFERRAL; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CROSS-SECTIONAL STUDIES; HIV INFECTIONS; HUMANS; PRIVATE SECTOR; QUESTIONNAIRES; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS;

EID: 79955538379     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2010.09.022     Document Type: Article

References (38)

1. Ammon L., Sterling S., Mertens J., Weisner C. Adolescents in private chemical dependency programs: who are at risk for HIV?. J. Subst. Abuse Treat. 2005, 29:39-45.
2. Brown L.S., Kritz S., Muhammad A., Bini E.J., Goldsmith R.J., Robinson J., Alderson D., Hasin D.S., Rotrosen J. Disparities in health services for HIV/AIDS, hepatitis C virus, and sexually transmitted infections: role of substance abuse treatment programs. J. Addict. Med. 2009, 3:95-102.
3. Brown L.S., Kritz S.A., Goldsmith R.J., Bini E.J., Rotrosen J., Baker S., Robinson J., McAuliffe P. Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: the National Drug Abuse Treatment Clinical Trials Network. J. Subst. Abuse Treat. 2006, 30:315-321.
4. Centers for Disease Control and Prevention Revised guidelines for HIV counseling testing, and referral. MMWR Morb. Mort. Wkly Rep. 2001, 50(RR-19):1-58.
5. Damanpour F. Organizational innovation: a metaanalysis of effects of determinants and moderators. Acad. Manage. J. 1991, 34:555-590.
6. D'Aunno T., Vaughn T.E., McElroy P. An institutional analysis of HIV prevention efforts by the nation's outpatient drug abuse treatment units. J. Health Soc. Behav. 1999, 40:175-192.
7. Deiss R. High-risk sexual and drug using behaviors among male injection drug users who have sex with men in 2 Mexico-US border cities. Sex. Transm. Dis. 2010, 35:243-249.
8. Des Jarlais D.C., Arasteh K., Perlis T., Hagan H., Abdul-Quader A., Heckathorn D.D., McKnight C., Bramson H., Nemeth C., Torian L.V., Friedman S.R. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS 2007, 21:231-235.
9. Ducharme L.J., Mello H.L., Roman P.M., Knudsen H.K., Johnson J.A. Service delivery in substance abuse treatment: reexamining " comprehensive" care. J. Behav. Health Serv. Res. 2007, 34:121-136.
10. Friedmann P.D., D'Aunno T.A., Jin L., Alexander J.A. Medical and psychosocial services in drug abuse treatment: do stronger linkages promote client utilization?. Health Serv. Res. 2000, 35:443-465.
11. Friedmann P.D., Lemon S.C., Durkin E.M., D'Aunno T.A. Trends in comprehensive service availability in outpatient drug abuse treatment. J. Subst. Abuse Treat. 2003, 24:81-88.
12. Institute of Medicine No Time to Lose: Getting More from HIV Prevention 2000, National Academy Press, Washington, DC.
13. Jemmott J.B., Jemmott L.S., Fong G.T. Reductions in HIV risk-associated sexual behaviors among black male adolescents: effects of an AIDS prevention intervention. Am. J. Public Health 1992, 82:372-377.
14. Knudsen H.K., Oser C.B. Availability of HIV-related health services in adolescent substance abuse treatment programs. AIDS Care 2009, 21:1238-1246.
15. Kritz S., Brown L.S., Goldsmith J., Bini E.J., Robinson J., Alderson D., Novo P., Rotrosen J. States and substance abuse treatment programs: funding and guidelines for infection-related services. Am. J. Public Health 2008, 98:824-826.
16. McLellan A.T., Arndt I.O., Metzger D.S., Woody G.E., O'Brien C.P. The effects of psychosocial services in substance abuse treatment. JAMA 1993, 269:1953-1959.
17. Metzger D.S., Navaline H., Woody G.E. Drug abuse treatment as AIDS prevention. Public Health Rep. 1998, 113(Suppl 1):97-106.
18. National Institute on Alcohol Abuse and Alcoholism Alcohol and HIV/AIDS. Alcohol Alert 2002, National Institute on Alcohol Abuse and Alcoholism, Washington, DC.
19. National Institute on Drug Abuse Principles of HIV Prevention in Drug-using Populations: A Research-based Guide 2002, National Institute on Drug Abuse, Washington, DC.
20. National Institute on Drug Abuse Research Report Series: HIV/AIDS 2006, National Institute on Drug Abuse, Washington, DC.
21. Oser C.B., Roman P.M. Organizational-level predictors of adoption across time: naltrexone in private substance-use disorders treatment centers. J. Stud. Alcohol Drugs 2007, 68:852-861.
22. Pollack H.A., D'Aunno T. HIV testing and counseling in the nation's outpatient substance abuse treatment system, 1995-2005. J. Subst. Abuse Treat. 2010, 38:307-316.
23. Pollack H.A., D'Aunno T., Lamar B. Outpatient substance abuse treatment and HIV prevention: an update. J. Subst. Abuse Treat. 2006, 30:39-47.
24. Rogers E.M. Diffusion of Innovations 2003, Free Press, New York.
25. Rotheram-Borus M.J. Expanding the range of interventions to reduce HIV among adolescents. AIDS 2000, 14(Suppl. 1):S33-S40.
26. Rothman J., Rudnick D., Slifer M., Agins B., Heiner K., Birkhead G. Co-located substance use treatment and HIV prevention and primary care services, New York State, 1990-2002: a model for effective service delivery to a high-risk population. J. Urban Health 2007, 84:226-242.
27. Simpson D.D., Joe G.W., Rowan-Szal G.A., Greener J.M. Drug abuse treatment process components that improve retention. J. Subst. Abuse Treat. 1997, 14:565-572.
28. Sorensen J.L., Copeland A.L. Drug abuse treatment as an HIV prevention strategy: a review. Drug Alcohol Depend. 2000, 59:17-31.
29. StataCorp Stata Statistical Software: Release 11 2009, StataCorp LP, College Station, TX.
30. St.Lawrence J.S., Crosby R.A., Brasfield T.L., O'Bannon R.E. Reducing STD and HIV risk behavior in substance-dependent adolescents: a randomized clinical trial. J. Consult. Clin. Psychol. 2002, 70:1010-1021.
31. St.Lawrence J.S., Jefferson K.W., Alleyne E., Brasfield T.L. Comparison of education versus behavioral skills training interventions in lowering sexual HIV-risk behavior in substance-dependent adolescents. J. Consult. Clin. Psychol. 1995, 63:154-157.
32. Strathdee S., Stockman J. Epidemiology of HIV among injecting and non-injecting drug users: current trends and implications for interventions. Curr. HIV/AIDS Rep. 2010, 7:99-106.
33. Strauss S.M., Des Jarlais D.C., Astone J., Vassilev Z.P. On-site HIV testing in residential drug treatment units: results of a nationwide survey. Public Health Rep. 2003, 118:37-43.
34. Substance Abuse and Mental Health Services Administration Substance Abuse Treatment for Persons with HIV/AIDS: Treatment Improvement Protocol (TIP) Series, Number 37. DHHS Pub. No. (SMA) 00-3410 2000, US Government Printing Office, Washington, DC.
35. Substance Abuse and Mental Health Services Administration The N-SSATS Report: Services Provided by Substance Abuse Treatment Facilities 2009, Substance Abuse and Mental Health Services Administration, Rockville, MD.
36. Umbricht-Schneiter A., Ginn D.H., Pabst K.M., Bigelow G.E. Providing medical care to methadone clinic patients: referral vs on-site care. Am. J. Public Health 1994, 84:207-210.
37. Volkow N.D., Montaner J. Enhanced HIV testing, treatment, and support for HIV-infected substance users. JAMA 2010, 303:1423-1424.
38. Winstock A.R., Anderson C.M., Sheridan J. National survey of HIV and hepatitis testing and vaccination services provided by drug and alcohol agencies in Australia. Med. J. Aust. 2006, 184:560-562.